Fleebs-Logo
Details werden geladen...

FDA Okays Finerenone for CKD in Adults With Type 1 Diabetes

It is the first new treatment in more than 30 years approved for treating chronic kidney disease in T1D.

Ähnliche Seiten

https://www.medscape.com/viewarticle/switching-dialysis-modalities-ups-mortality-older-adults-2026a1000x7u

Switching Dialysis Modalities Ups Mortality in Older Adults

https://www.medscape.com/viewarticle/switching-dialysis-modalities-ups-mortality-older-adults-2026a1000x7u
https://www.finanznachrichten.de/nachrichten-2026-05/68557764-bayer-wins-fda-priority-review-for-kerendia-in-chronic-kidney-disease-with-type-1-diabetes-020.htm

Bayer Wins FDA Priority Review For Kerendia In Chronic Kidney Disease With Type 1 Diabetes

https://www.finanznachrichten.de/nachrichten-2026-05/68557764-bayer-wins-fda-priority-review-for-kerendia-in-chronic-kidney-disease-with-type-1-diabetes-020.htm
https://www.finanzen.ch/nachrichten/aktien/bayer-fda-approves-kerendia-to-treat-chronic-kidney-disease-associated-with-type-1-diabetes-1036552592

Bayer: FDA Approves Kerendia To Treat Chronic Kidney Disease Associated With Type 1 Diabetes | 17.09.26 | finanzen.ch

https://www.finanzen.ch/nachrichten/aktien/bayer-fda-approves-kerendia-to-treat-chronic-kidney-disease-associated-with-type-1-diabetes-1036552592
https://www.indiatoday.in/health/story/once-weekly-insulin-awiqli-launched-in-india-for-adults-with-type-1-and-type-2-diabetes-2943877-2026-07-09

Once-weekly insulin Awiqli launched in India for adults with Type 1 and Type 2 diabetes - India Today

https://www.indiatoday.in/health/story/once-weekly-insulin-awiqli-launched-in-india-for-adults-with-type-1-and-type-2-diabetes-2943877-2026-07-09
https://www.medscape.com/viewarticle/cardiometabolic-risks-emerge-early-after-gestational-2026a1000x34

Cardiometabolic Risks Arise Early After Gestational Diabetes

https://www.medscape.com/viewarticle/cardiometabolic-risks-emerge-early-after-gestational-2026a1000x34
https://www.finanzen.at/nachrichten/aktien/fda-approves-mannkinds-afrezza-for-children-and-adolescents-with-type-1-and-type-2-diabetes-1036209733

FDA Approves MannKind's Afrezza For Children And Adolescents With Type 1 And Type 2 Diabetes | 31.05.26 | finanzen.at

https://www.finanzen.at/nachrichten/aktien/fda-approves-mannkinds-afrezza-for-children-and-adolescents-with-type-1-and-type-2-diabetes-1036209733